A phase 2 liver trial where the add-on drug didn't help — and the base drug quietly did
Read the Sunday Brief →

Study wrapper · #378

[Biological activity of regulatory peptides in model experiments in vitro].

Kozina LS, Arutiunian AV, Stvolinskiĭ SL, et al. Advances in gerontology = Uspekhi gerontologii. 2008.
PubMed: 18546826
Weak / noneIn vitroMentions: Epitalon

Editor's note

This in-vitro study tested several short regulatory peptides — pinealon, vesugen, vilon, and epitalon — in cell and biochemical models. Notably, researchers reported that these peptides showed no direct antioxidant activity, but could limit lipid peroxidation of human lipoproteins by altering their structure, increase red-blood-cell membrane stability against osmotic rupture, and raise steady-state intracellular reactive-oxygen-species levels while (for all except epitalon) reducing the proportion of dead cells in a neuronal population. The authors hypothesise a role in regulating apoptosis/necrosis. The finding that these peptides lack direct antioxidant action is a useful corrective to a common claim about epitalon, and is consistent with the note in its own mechanism literature that any antioxidant effect is not well characterised. This is preclinical, cell-level work with mechanistic endpoints; epitalon was in fact the exception to the cell-survival effect here. Human data are needed before any clinical conclusions can be drawn.

Plain-language abstract

This laboratory study tested four short peptides — pinealon, vesugen, vilon, and epitalon — in cell and test-tube models to look at their biological effects. The researchers reported that the peptides did not act as direct antioxidants. However, they could limit oxidative damage to human blood-fat particles (lipoproteins) by changing the particles' structure, and they made red blood cells more resistant to bursting in a salt-imbalance test. The peptides also raised the baseline level of reactive oxygen molecules inside cells; at the same time, all of the peptides except epitalon reduced the share of dead cells in a group of nerve cells. The authors suggest the peptides may help regulate how cells die (by apoptosis or necrosis). This is important because it pushes back on the idea that these peptides are direct antioxidants. The work was done entirely in cells and test tubes, with no animal or human testing and no side-effect data.